Report of national brain tumor society roundtable workshop on innovating brain tumor clinical trials: Building on lessons learned from COVID-19 experience

Eudocia Q. Lee; Wendy Selig; Clair Meehan; Jeffrey Bacha; Amy Barone; Erik Bloomquist; Susan M. Chang; John F. De Groot; Evanthia Galanis; Islam Hassan; Chitkala Kalidas; Mustafa Khasraw; Joseph C. Kvedar; Andrew B. Lassman; Vinay Puduvalli; Solmaz Sahebjam; Lee H. Schwamm; Sharon Tamir; Mary Welch; W. K.Alfred Yung; Gelareh Zadeh; David Arons; Patrick Y. Wen

doi:10.1093/neuonc/noab082

Report of national brain tumor society roundtable workshop on innovating brain tumor clinical trials: Building on lessons learned from COVID-19 experience

Eudocia Q. Lee, Wendy Selig, Clair Meehan, Jeffrey Bacha, Amy Barone, Erik Bloomquist, Susan M. Chang, John F. De Groot, Evanthia Galanis, Islam Hassan, Chitkala Kalidas, Mustafa Khasraw, Joseph C. Kvedar, Andrew B. Lassman, Vinay Puduvalli, Solmaz Sahebjam, Lee H. Schwamm, Sharon Tamir, Mary Welch, W. K.Alfred YungGelareh Zadeh, David Arons, Patrick Y. Wen

Medical Oncology

Research output: Contribution to journal › Article › peer-review

Abstract

On July 24, 2020, a workshop sponsored by the National Brain Tumor Society was held on innovating brain tumor clinical trials based on lessons learned from the COVID-19 experience. Various stakeholders from the brain tumor community participated including the US Food and Drug Administration (FDA), academic and community clinicians, researchers, industry, clinical research organizations, patients and patient advocates, and representatives from the Society for Neuro-Oncology and the National Cancer Institute. This report summarizes the workshop and proposes ways to incorporate lessons learned from COVID-19 to brain tumor clinical trials including the increased use of telemedicine and decentralized trial models as opportunities for practical innovation with potential long-term impact on clinical trial design and implementation.

Original language	English (US)
Pages (from-to)	1252-1260
Number of pages	9
Journal	Neuro-oncology
Volume	23
Issue number	8
DOIs	https://doi.org/10.1093/neuonc/noab082
State	Published - Aug 1 2021

Keywords

COVID-19
clinical trials
decentralization
telemedicine

ASJC Scopus subject areas

Oncology
Clinical Neurology
Cancer Research

Access to Document

10.1093/neuonc/noab082

Cite this

Lee, E. Q., Selig, W., Meehan, C., Bacha, J., Barone, A., Bloomquist, E., Chang, S. M., De Groot, J. F., Galanis, E., Hassan, I., Kalidas, C., Khasraw, M., Kvedar, J. C., Lassman, A. B., Puduvalli, V., Sahebjam, S., Schwamm, L. H., Tamir, S., Welch, M., ... Wen, P. Y. (2021). Report of national brain tumor society roundtable workshop on innovating brain tumor clinical trials: Building on lessons learned from COVID-19 experience. Neuro-oncology, 23(8), 1252-1260. https://doi.org/10.1093/neuonc/noab082

Lee, EQ, Selig, W, Meehan, C, Bacha, J, Barone, A, Bloomquist, E, Chang, SM, De Groot, JF, Galanis, E, Hassan, I, Kalidas, C, Khasraw, M, Kvedar, JC, Lassman, AB, Puduvalli, V, Sahebjam, S, Schwamm, LH, Tamir, S, Welch, M, Yung, WKA, Zadeh, G, Arons, D & Wen, PY 2021, 'Report of national brain tumor society roundtable workshop on innovating brain tumor clinical trials: Building on lessons learned from COVID-19 experience', Neuro-oncology, vol. 23, no. 8, pp. 1252-1260. https://doi.org/10.1093/neuonc/noab082

@article{6bac530610d24955874a17c0c2c0c2c0,

title = "Report of national brain tumor society roundtable workshop on innovating brain tumor clinical trials: Building on lessons learned from COVID-19 experience",

abstract = "On July 24, 2020, a workshop sponsored by the National Brain Tumor Society was held on innovating brain tumor clinical trials based on lessons learned from the COVID-19 experience. Various stakeholders from the brain tumor community participated including the US Food and Drug Administration (FDA), academic and community clinicians, researchers, industry, clinical research organizations, patients and patient advocates, and representatives from the Society for Neuro-Oncology and the National Cancer Institute. This report summarizes the workshop and proposes ways to incorporate lessons learned from COVID-19 to brain tumor clinical trials including the increased use of telemedicine and decentralized trial models as opportunities for practical innovation with potential long-term impact on clinical trial design and implementation.",

keywords = "COVID-19, clinical trials, decentralization, telemedicine",

author = "Lee, {Eudocia Q.} and Wendy Selig and Clair Meehan and Jeffrey Bacha and Amy Barone and Erik Bloomquist and Chang, {Susan M.} and {De Groot}, {John F.} and Evanthia Galanis and Islam Hassan and Chitkala Kalidas and Mustafa Khasraw and Kvedar, {Joseph C.} and Lassman, {Andrew B.} and Vinay Puduvalli and Solmaz Sahebjam and Schwamm, {Lee H.} and Sharon Tamir and Mary Welch and Yung, {W. K.Alfred} and Gelareh Zadeh and David Arons and Wen, {Patrick Y.}",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s) 2021.",

year = "2021",

month = aug,

day = "1",

doi = "10.1093/neuonc/noab082",

language = "English (US)",

volume = "23",

pages = "1252--1260",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Report of national brain tumor society roundtable workshop on innovating brain tumor clinical trials

T2 - Building on lessons learned from COVID-19 experience

AU - Lee, Eudocia Q.

AU - Selig, Wendy

AU - Meehan, Clair

AU - Bacha, Jeffrey

AU - Barone, Amy

AU - Bloomquist, Erik

AU - Chang, Susan M.

AU - De Groot, John F.

AU - Galanis, Evanthia

AU - Hassan, Islam

AU - Kalidas, Chitkala

AU - Khasraw, Mustafa

AU - Kvedar, Joseph C.

AU - Lassman, Andrew B.

AU - Puduvalli, Vinay

AU - Sahebjam, Solmaz

AU - Schwamm, Lee H.

AU - Tamir, Sharon

AU - Welch, Mary

AU - Yung, W. K.Alfred

AU - Zadeh, Gelareh

AU - Arons, David

AU - Wen, Patrick Y.

PY - 2021/8/1

Y1 - 2021/8/1

N2 - On July 24, 2020, a workshop sponsored by the National Brain Tumor Society was held on innovating brain tumor clinical trials based on lessons learned from the COVID-19 experience. Various stakeholders from the brain tumor community participated including the US Food and Drug Administration (FDA), academic and community clinicians, researchers, industry, clinical research organizations, patients and patient advocates, and representatives from the Society for Neuro-Oncology and the National Cancer Institute. This report summarizes the workshop and proposes ways to incorporate lessons learned from COVID-19 to brain tumor clinical trials including the increased use of telemedicine and decentralized trial models as opportunities for practical innovation with potential long-term impact on clinical trial design and implementation.

AB - On July 24, 2020, a workshop sponsored by the National Brain Tumor Society was held on innovating brain tumor clinical trials based on lessons learned from the COVID-19 experience. Various stakeholders from the brain tumor community participated including the US Food and Drug Administration (FDA), academic and community clinicians, researchers, industry, clinical research organizations, patients and patient advocates, and representatives from the Society for Neuro-Oncology and the National Cancer Institute. This report summarizes the workshop and proposes ways to incorporate lessons learned from COVID-19 to brain tumor clinical trials including the increased use of telemedicine and decentralized trial models as opportunities for practical innovation with potential long-term impact on clinical trial design and implementation.

KW - COVID-19

KW - clinical trials

KW - decentralization

KW - telemedicine

UR - http://www.scopus.com/inward/record.url?scp=85109155824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109155824&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noab082

DO - 10.1093/neuonc/noab082

M3 - Article

C2 - 33822177

AN - SCOPUS:85109155824

SN - 1522-8517

VL - 23

SP - 1252

EP - 1260

JO - Neuro-oncology

JF - Neuro-oncology

IS - 8

ER -

Report of national brain tumor society roundtable workshop on innovating brain tumor clinical trials: Building on lessons learned from COVID-19 experience

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this